Skip to main content
Caplight Logo









Thalamos

Thalamos

Private
LondonHealthcare & Life Scienceshttps://www.thalamos.co.uk/

Last Round

Seed

Sep 1, 2022

Total Funding Raised

$1.07M

Company Overview

Thalamos is a healthtech company that provides a digital platform for mental healthcare professionals to digitize and streamline the Mental Health Act process.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Document Management, Compliance, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

mental health actMHAeMHAdigital healthNHS softwareclinical workflowhealthcare complianceelectronic patient recordEPRhealthtechvertical SaaSdocument managementworkflow automationstatutory documentationhealth IT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Thalamos Comparables

Compare Thalamos with similar companies based on industry and business-model similarity.

Thalamos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vitalhub Corp
80%
The Access Group
72%
System C Healthcare Limited
71%

Thalamos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2022
AcceleratorMar 31, 2022

Key People

Founding team and executive leadership

Ross Tomison

COO Co-Founder

Founding Team

Arden Tomison

Founder & CEO

Founding Team

Thalamos Investors

Notable investors and investment history

Thalamos investors
InvestorRounds
NHS Innovation AcceleratorAccelerator
SeedrsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2022

    $1M round led by Conduit EIS Impact Fund.

Thalamos Filings

Explore SEC and related filing metadata, where available.

Thalamos filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Thalamos's valuation, stock price, and market status.

Is Thalamos a public or private company?

Thalamos is a private company.

What is the current stock price of Thalamos?

Thalamos is a private company with no public stock price. No recent secondary market data is available.

How much is Thalamos worth (valuation)?

Valuation information for Thalamos is not publicly available.

Can I buy Thalamos stock?

Thalamos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Thalamos's last funding round?

Thalamos's most recent funding round was Seed on September 1, 2022.

Who are the main investors in Thalamos?

Key investors in Thalamos include NHS Innovation Accelerator, Seedrs.

Will Thalamos IPO soon?

No public IPO plans have been announced for Thalamos.

How can I track Thalamos secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Thalamos's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range24
Year Founded2017
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?